QKA

Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia

Product code
QKA
Device name
Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia
Device class
Class 2
21 CFR
21 CFR 876.5510
Medical specialty
Gastroenterology, Urology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
2
Summaries archived here
2 (direct download)
510(k) clearances (all years, FDA)
4 (all years; only the last 3 years are listed here)

FDA classification definition

A system intended for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men age 50 and above.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (2)

Last three years. Most recent: 2026-06-22.

NumberDecision dateApplicantDevice nameSummary
K2613422026-06-22Prodeon Medical, Inc.Urocross Expander System (UES-2018-C1)PDF
K2535252026-03-12Prodeon Medical, Inc.Urocross Expander System (Model Numbers ES2018 and E…PDF

2 summaries are archived here for direct download.

Official FDA classification page: QKA
Classification and pathway per current FDA publications. Data from openFDA (CC0).